Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Type 2 helper T cell cytokines (most notably interleukin-4, interleukin-5, interleukin-9, interleukin-13, and sometimes interleukin-10 or IL-25) are a group of signaling molecules secreted principally by Type 2 helper T (Th2) cells. They promote humoral immunity by stimulating B cell class switching (especially to IgE), recruiting eosinophils, basophils, and mast cells, and facilitating responses to extracellular parasites and allergens. These cytokines mediate tissue repair and fibrosis but are also involved in the pathogenesis of allergic diseases such as asthma and atopic dermatitis as well as certain fibrotic conditions. Because 'Type 2 helper T cell cytokines' describes a broad class of signaling molecules rather than a single target, it is not a precise molecular target suitable for direct drug intervention as a unit; rather, individual cytokines (e.g., IL-4, IL-5, or IL-13) are therapeutic targets in various disease contexts.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Type 2 helper T cell cytokine (Th2 cytokine).